ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IIIA BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if the combination is safe and helps the immune system fight cancer more effectively. Ab…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Custom-Made vaccine takes on Triple-Negative breast cancer
Disease control Recruiting nowThis early-phase trial is testing a personalized vaccine made from a patient's own tumor, given alone or with drugs that boost the immune system (pembrolizumab or ipilimumab). The goal is to see if the combination is safe and can help the immune system attack triple-negative brea…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Could a shorter, less toxic treatment be just as effective for early breast cancer?
Disease control Recruiting nowThis study is for people with early-stage triple-negative breast cancer. It compares a shorter chemo-immunotherapy regimen without anthracyclines (a type of strong chemo) to the usual longer treatment. The goal is to see if the shorter approach works just as well while reducing s…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
Can new drug combos outsmart PARP resistance in BRCA breast cancer?
Disease control Recruiting nowThis phase 2 trial tests whether adding cediranib or ceralasertib to olaparib can overcome resistance in BRCA-mutated advanced breast cancer. About 60 participants with HER2-negative, BRCA-positive tumors that have progressed on prior therapy will receive one of the two drug comb…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Could a pill replace chemo for some breast cancers? major trial launches
Disease control Recruiting nowThis study compares two treatments for people with high-stage, estrogen-positive, HER2-negative breast cancer that has a low genetic risk of returning. One group gets standard hormone therapy plus a targeted pill (ribociclib), while the other gets chemotherapy first, then the sam…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
BREAST CANCER BREAKTHROUGH: thousands could avoid unnecessary treatment
Disease control Recruiting nowThis study is for people with early-stage triple-negative breast cancer whose tumors completely disappeared after initial chemotherapy plus immunotherapy (pembrolizumab). It compares the usual approach of continuing pembrolizumab for 27 more weeks versus simply watching and waiti…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New drug combo shows promise in shrinking tough breast cancer before surgery
Disease control Recruiting nowThis study tests whether adding the drug darolutamide to standard chemotherapy and immunotherapy before surgery can shrink tumors more effectively in people with early-stage androgen receptor positive triple-negative breast cancer. About 51 participants will receive either standa…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Electric field device joins forces with cancer drugs in early trial
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to find …
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
CBD oil tested for breast cancer drug side effect
Symptom relief Recruiting nowThis study tests whether a high-CBD plant extract can reduce joint stiffness and pain in women with breast cancer who take aromatase inhibitors. These drugs lower estrogen to prevent cancer return but often cause painful joints, leading some women to stop treatment. The trial wil…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 23, 2026 11:54 UTC
-
Exercise may sharpen memory in breast cancer survivors
Symptom relief Recruiting nowThis study tests whether a community-based exercise program can improve memory, attention, and brain health in women who have had breast cancer. About 160 survivors, aged 50 and older, will either take part in aerobic exercise or health education sessions. The goal is to see if p…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 22, 2026 12:03 UTC
-
Can a baldness drug save hair during breast cancer treatment?
Symptom relief Recruiting nowThis study looks at whether minoxidil (a hair growth drug) can help with hair loss caused by hormone therapy in breast cancer patients. About 50 women with stage I-IV breast cancer who are on hormone therapy and have noticed hair thinning will either take minoxidil pills or apply…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 16, 2026 12:55 UTC
-
Laser therapy offers hope for breast cancer survivors suffering from vaginal dryness
Symptom relief Recruiting nowThis study tests a laser treatment for vaginal dryness in breast cancer survivors. Many survivors experience this side effect from cancer treatments like chemotherapy or hormone therapy. The trial will compare the laser to no treatment in 250 women to see if it improves symptoms.
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
New tool aims to help breast cancer patients decide on preventive surgery
Knowledge-focused Recruiting nowThis study tests a decision-making tool for women newly diagnosed with breast cancer who are considering whether to have the healthy breast removed preventively (contralateral prophylactic mastectomy). The tool is designed to provide clear, balanced information. Researchers will …
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC
-
Can your social life help you beat Cancer's aftermath? new study investigates
Knowledge-focused Recruiting nowThis study looks at how personal relationships and physical activity influence the quality of life of young adults (ages 18-39) who have been diagnosed with cancer. Researchers will track 250 participants over time to see how social connections and exercise habits change and affe…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC